What is KVUE's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 34.06B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for KVUE?

P/E (TTM) is 20.54 and 52-week range is $14.02 to $20.13 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s KVUE figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for KVUE?

The company profile lists revenue (TTM) near $15.38B, net income (TTM) near $1.66B, EPS (TTM) near $0.86 when available from the market-data feed. Figures are informational and may lag live markets.

Does KVUE show a dividend on Chartloom?

The overview lists dividend per share (TTM) near $0.83, yield near 4.67%, ex-dividend date Sep 21, 2026 when those figures are present. Dividend history is compiled from vendor data, not a distribution notice.

Where is Kenvue Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Summit, New Jersey, US, 1.92B shares outstanding, ISIN US49177J1025 when available from company profile and filing metadata.

Kenvue Inc

$KVUE

Consumer Staples · Personal Care Products

IR Run Scenarios

$17.70

-0.17%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. The company is headquartered in Summit, New Jersey and currently employs 21,780 full-time employees. The company went IPO on 2023-05-04. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).

Employees

21,890

Website

www.kenvue.com

IPO

2023-05-04

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)